Edward Morrow Iii Atkinson Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 14 minutes ago
Edward Morrow Iii Atkinson has an estimated net worth of at least $20.7 million*, as of today. They own 18,432 shares of VRTX stock. They have sold 41,267 shares of VRTX stock since 2021, for an estimated $11.6 million.
Edward Morrow Iii Atkinson $VRTX SEC Form 4 Insider Trading
Edward Morrow Iii Atkinson has filed a total of 13 insider trades in $VRTX since 2021. Their most recent trade was a sale of 668 shares, made on Feb 25, 2026. Their largest trade was a sale of 7,288 shares, made on Jun 12, 2024. We estimate that they now own 18,432 shares of $VRTX, worth an estimated $9.1 million.
Insider Trading at $VRTX
There have been a total of 561 insider trades reported at $VRTX since 2021, with 40,000 shares purchased and 1.1 million shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Ourania Tatsis, and Bastiano Sanna. The most recent trade was a sale of 2,437 shares reported by Duncan McKechnie (EVP, Chief Commercial Officer), made on Mar 04, 2026.
History of Insider Stock Trades by Edward Morrow Iii Atkinson
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Sale | 668 | Feb 25, 2026 | Feb. 26, 2026, 7 p.m. |
|
VRTX
|
Sale | 817 | Feb 18, 2026 | Feb. 19, 2026, 5:06 p.m. |
|
VRTX
|
Sale | 2,031 | Feb 17, 2026 | Feb. 19, 2026, 5:06 p.m. |
|
VRTX
|
Sale | 1,751 | Feb 11, 2026 | Feb. 12, 2026, 5:50 p.m. |
|
VRTX
|
Sale | 2,500 | Nov 17, 2025 | Nov. 19, 2025, 5:06 p.m. |
|
VRTX
|
Sale | 2,650 | Feb 27, 2025 | Feb. 28, 2025, 5:36 p.m. |
|
VRTX
|
Sale | 1,767 | Feb 25, 2025 | Feb. 26, 2025, 5:09 p.m. |
|
VRTX
|
Sale | 1,747 | Feb 11, 2025 | Feb. 12, 2025, 5:29 p.m. |
|
VRTX
|
Sale | 7,288 | Jun 12, 2024 | June 13, 2024, 4:09 p.m. |
|
VRTX
|
Sale | 883 | Feb 26, 2024 | Feb. 27, 2024, 5:44 p.m. |
|
VRTX
|
Sale | 1,201 | Feb 21, 2024 | Feb. 23, 2024, 5:16 p.m. |
|
VRTX
|
Sale | 801 | Feb 20, 2024 | Feb. 21, 2024, 5:23 p.m. |
|
VRTX
|
Sale | 913 | Feb 12, 2024 | Feb. 13, 2024, 5:54 p.m. |
ETNB
|
Sale | 6,250 | Jun 01, 2023 | June 5, 2023, 5:03 p.m. |
|
ETNB
|
Sale | 10,000 | Mar 01, 2023 | March 3, 2023, 6:18 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Stuart A Arbuckle, EVP, COO
-
Jeffrey M Leiden, Executive Chairman
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Reshma Kewalramani, CEO & President
-
Joy Liu, SVP, General Counsel
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Carmen Bozic, EVP and CMO
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Jonathan Biller, EVP and Chief Legal Officer
-
David Altshuler, EVP, Chief Scientific Officer
-
Mark E. Bunnage, EVP, Chief Scientific Officer
-
Amit Sachdev, EVP, Chief Patient Officer
-
Duncan Mckechnie, EVP, Chief Commercial Officer
-
Charles F Jr Wagner, EVP, CO & FO
-
Joy Liu, EVP and Chief Legal Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.